http://www.sharekhan.com/CMT/Upload/NewsLetter/Report/InvestorsEye-May18_15.pdf
Info from May 2015 report
Minocycline: Torrent Pharma purchased an antibacterial drug, minocycline tablets and capsules, in the USA, which was divested by Ranbaxy Laboratories (Ranbaxy) under the direction of the US competition commission (as a condition of merger with Sun Pharmaceutical Industries). The market size of the product is pegged at $700 million and Ranbaxy held a market share close to 27%. Torrent Pharma has already launched this product in April 2015.
| Subscribe To Our Free Newsletter |
